News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
251,330 Results
Type
Article (10167)
Company Profile (17)
Press Release (241143)
Multimedia
Podcasts (26)
Webinars (2)
Section
Business (62966)
Career Advice (934)
Deals (13399)
Drug Delivery (27)
Drug Development (29604)
Employer Resources (30)
FDA (8013)
Job Trends (4876)
News (119046)
Policy (15720)
Tag
2027 Pharm Country Standard (2)
Academia (750)
Accelerated approval (29)
Adcomms (21)
Allergies (77)
Alliances (18055)
ALS (96)
Alzheimer's disease (679)
Antibody-drug conjugate (ADC) (191)
Approvals (8155)
Artificial intelligence (291)
Autoimmune disease (95)
Automation (27)
Bankruptcy (96)
Best Places to Work (4323)
Biosimilars (75)
Biotechnology (24)
Bladder cancer (91)
Brain cancer (36)
Breast cancer (314)
Cancer (2453)
Cardiovascular disease (181)
Career advice (751)
Career pathing (10)
CAR-T (128)
CDC (9)
Cell therapy (357)
Cervical cancer (15)
Clinical research (26183)
Collaboration (846)
Company closure (2)
Compensation (786)
Complete response letters (79)
COVID-19 (911)
CRISPR (55)
C-suite (340)
Cystic fibrosis (62)
Data (3162)
Denatured (5)
Depression (76)
Dermatology (41)
Diabetes (188)
Diagnostics (2822)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (7)
Drug discovery (121)
Drug pricing (22)
Drug shortages (2)
Duchenne muscular dystrophy (125)
Earnings (31386)
Editorial (9)
Employer branding (3)
Employer resources (26)
Events (29115)
Executive appointments (335)
FDA (10199)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (18)
Funding (658)
Gene editing (125)
Generative AI (31)
Gene therapy (296)
GLP-1 (320)
Government (1415)
Grass and pollen (2)
Guidances (234)
Healthcare (5676)
HIV (35)
Huntington's disease (27)
IgA nephropathy (46)
Immunology and inflammation (104)
Immuno-oncology (38)
Indications (90)
Infectious disease (1043)
Inflammatory bowel disease (94)
Inflation Reduction Act (1)
Influenza (54)
Intellectual property (198)
Interviews (207)
IPO (7198)
IRA (6)
Job creations (693)
Job search strategy (581)
JPM (21)
Kidney cancer (5)
Labor market (35)
Layoffs (137)
Leadership (6)
Legal (2123)
Liver cancer (45)
Longevity (13)
Lung cancer (337)
Lymphoma (194)
Machine learning (25)
Management (7)
Manufacturing (370)
MASH (92)
Medical device (5382)
Medtech (5417)
Mergers & acquisitions (6908)
Metabolic disorders (467)
mRNA (61)
Multiple sclerosis (99)
NASH (7)
Neurodegenerative disease (169)
Neuropsychiatric disorders (39)
Neuroscience (1311)
NextGen: Class of 2026 (1757)
Non-profit (736)
Now hiring (12)
Obesity (178)
Opinion (80)
Ovarian cancer (61)
Pain (105)
Pancreatic cancer (117)
Parkinson's disease (120)
Partnered (19)
Patents (412)
Patient recruitment (228)
Peanut (31)
People (14892)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (7519)
Phase 2 (10517)
Phase 3 (10781)
Pipeline (4054)
Policy (77)
Postmarket research (533)
Preclinical (3389)
Press Release (44)
Prostate cancer (128)
Psychedelics (27)
Radiopharmaceuticals (158)
Rare diseases (546)
Real estate (1228)
Recruiting (16)
Regulatory (15141)
Reports (29)
Research institute (633)
Resumes & cover letters (244)
Rett syndrome (26)
RNA editing (11)
RSV (23)
Schizophrenia (74)
Series A (100)
Series B (63)
Service/supplier (2)
Sickle cell disease (33)
Special edition (12)
Spinal muscular atrophy (82)
Sponsored (16)
Startups (987)
State (1)
Stomach cancer (6)
Supply chain (42)
Tariffs (12)
The Weekly (20)
Vaccines (341)
Venture capital (25)
Weight loss (94)
Women's health (30)
Worklife (2)
Date
Today (60)
Last 7 days (259)
Last 30 days (1185)
Last 365 days (13518)
2026 (4014)
2025 (13522)
2024 (15389)
2023 (17419)
2022 (23682)
2021 (23502)
2020 (20858)
2019 (15780)
2018 (11510)
2017 (12119)
2016 (10377)
2015 (12252)
2014 (8552)
2013 (7358)
2012 (8136)
2011 (8586)
2010 (7573)
Location
Africa (189)
Alabama (64)
Alaska (1)
Arizona (63)
Arkansas (3)
Asia (16193)
Australia (2861)
California (5175)
Canada (2340)
China (683)
Colorado (233)
Connecticut (301)
Delaware (158)
Europe (34699)
Florida (905)
Georgia (248)
Hawaii (3)
Idaho (16)
Illinois (359)
India (34)
Indiana (266)
Iowa (14)
Japan (244)
Kansas (62)
Kentucky (9)
Louisiana (8)
Maine (38)
Maryland (550)
Massachusetts (3537)
Michigan (150)
Minnesota (244)
Mississippi (2)
Missouri (42)
Montana (8)
Nebraska (7)
Nevada (39)
New Hampshire (34)
New Jersey (1427)
New Mexico (18)
New York (1610)
North Carolina (609)
North Dakota (6)
Northern California (2537)
Ohio (133)
Oklahoma (2)
Oregon (3)
Pennsylvania (1136)
Puerto Rico (13)
Rhode Island (20)
South America (348)
South Carolina (14)
Southern California (2097)
Tennessee (58)
Texas (912)
United States (18739)
Utah (195)
Vermont (1)
Virginia (97)
Washington D.C. (18)
Washington State (408)
West Virginia (2)
Wisconsin (60)
Wyoming (1)
251,330 Results for "ion beam applications iba".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data
Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair.
March 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
IBA – ACQUISITION OF OWN SHARES - April 7, 2026
April 8, 2026
·
2 min read
Gene editing
Pfizer Advances Beam’s Gene Editor After Pulling Hemophilia Gene Therapy
Pfizer will be responsible for all global clinical and regulatory activities for Beam Therapeutics’ liver-directed gene editor.
February 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy
March 23, 2026
·
3 min read
Press Releases
IBA – ACQUISITION OF OWN SHARES
February 23, 2026
·
2 min read
Press Releases
IBA Notice of Full Year 2025 Results and Conference Call
March 13, 2026
·
1 min read
Press Releases
IBA – ACQUISITION OF OWN SHARES - March 2, 2026
March 3, 2026
·
2 min read
Press Releases
IBA – TRANSPARENCY NOTIFICATION - February 25, 2026
February 26, 2026
·
2 min read
Press Releases
IBA delivers strong FY 2025 results with solid execution in all segments
March 27, 2026
·
5 min read
Press Releases
Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.
March 20, 2026
·
5 min read
1 of 25,133
Next
